Poland· PL-100081969
Fragmin
A dalteparin product containing dalteparinum natricum, registered in Poland by Pfizer Europe MA EEIG. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dalteparin is registered in 13 of 19 countries.
Countries holding a registration under ATC B01AB04 (dalteparin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Dalteparin · ATC B01AB04
13 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
URPL (Poland)- Active substance
- Dalteparinum natricum
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Poland (PL)
- ATC code
- B01AB04
- ATC class
- Dalteparin
- Defined daily dose
- 2.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990776412
- gtin05909990939527
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
203 interactions on record for dalteparin.
Graded by severity as the source publishes them — 106 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dalteparin · interactions on record
203 records
- 106 severe
- 73 moderate
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
24 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dalteparin in 6 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDalteparin sodium 10,000units/0.4ml solution for injection pre-filled syringesJ M McGill Ltd
- NetherlandsFragmin 10.000 IE/0,4 ml, oplossing voor injectieEuro Registratie Collectief B.V.
- SwitzerlandFragmin
- SpainFRAGMIN 10.000 UI/0,4 ml SOLUCION INYECTABLE EN JERINGAS PRECARGADASPfizer S.L.
- FranceFRAGMINE 10 000 U.I. anti Xa/1 mL, solution injectable en seringue pré-rempliePFIZER HOLDING FRANCE
- IcelandFragminPfizer ApS
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d96b5009-743e-4c08-b51b-0d749f4de35c GET /v1/drugs/d96b5009-743e-4c08-b51b-0d749f4de35c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "2500 j.m. a.Xa/0,2 ml",
"packaging": "05909990776412 ¦ Rp ¦ 47040\n10 amp.-strzyk. 0,2 ml\n05909990939527 ¦ Rp ¦ 73002\n20 amp.-strzyk. 0,2 ml",
"substance": "Dalteparinum natricum 2500 IU(anty-faktor Xa)",
"common_name": "Dalteparinum natricum",
"pl_product_id": "100081969",
"pozwolenie_nr": "07764",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about dalteparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.